Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | CASP7 | P55210 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CDC14B | O60729 | 1/20 | 0.37 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.37 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.37 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.37 |
| ▸ | AHR | P35869 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30526462 | 1.00 | MAOA (0.39) | MAOAALDH1A1KDM4EMAPTHPGD | |
| SCHEMBL26255397 | 0.92 | MAOA (0.36) | MAOAALDH1A1KDM4EMAPTHPGD | |
| SCHEMBL20363781 | 0.91 | HPGD (0.46) | MAOAALDH1A1KDM4EMAPTHPGD | |
| SCHEMBL23504657 | 0.88 | ALOX5 (0.38) | MAOAALDH1A1KDM4EMAPTHPGD | |
| SCHEMBL24662708 | 0.88 | AHR (0.42) | MAOAALDH1A1KDM4EMAPTHPGD | |
| SCHEMBL19227534 | 0.87 | MAOA (0.41) | MAOAALDH1A1KDM4EMAPTHPGD | |
| SCHEMBL26238953 | 0.85 | ALOX5 (0.39) | MAOAALDH1A1KDM4EMAPTHPGD | |
| SCHEMBL30933211 | 0.85 | MAOA (0.34) | MAOAALDH1A1KDM4EMAPTHPGD | |
| SCHEMBL28536390 | 0.85 | AHR (0.55) | MAOAALDH1A1KDM4EMAPTHPGD | |
| SCHEMBL24663135 | 0.84 | MAOA (0.36) | MAOAALDH1A1KDM4EMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240237384-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SFC CO., LTD. (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240237384-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SFC CO., LTD. (KR) | 2024-07-11 | — | — | US | disclosed |
| US-20240237383-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SFC CO., LTD. (KR) | 2024-07-11 | — | — | US | disclosed |
| CN-111602258-B | Organic light emitting device | 株式会社LG化学 | 2023-11-07 | — | — | CN | disclosed |
| US-20230331639-A1 | METHOD FOR PREPARING DEUTERATED COMPOUND | LG CHEM, LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230320214-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND | LG CHEM, LTD. (KR) | 2023-10-05 | — | — | US | disclosed |
| US-20230320214-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND | LG CHEM, LTD. (KR) | 2023-10-05 | — | — | US | disclosed |
| CN-112341470-B | Electron transport material, organic electroluminescent device and display device | 烟台京师材料基因组工程研究院 | 2022-11-22 | — | — | CN | disclosed |
| WO-2022169218-A1 | METHOD FOR PREPARATION OF DEUTERATED ANTHRACENE COMPOUND, REACTION COMPOSITION, DEUTERATED ANTHRACENE COMPOUND, AND COMPOSITION | 주식회사 엘지화학 | 2022-08-11 | — | — | WO | disclosed |
| WO-2022139525-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND | 주식회사 엘지화학 | 2022-06-30 | — | — | WO | disclosed |
| CN-112341470-A | Electron transport material, organic electroluminescent device and display device | 烟台京师材料基因组工程研究院 | 2021-02-09 | — | — | CN | disclosed |
| CN-111602258-A | Organic light emitting device | 株式会社LG化学 | 2020-08-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230320214-A1 | ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND | CYP1A1, AOX1, CYP1B1 | MAOA 637/4885ALDH1A1 8/4885KDM4E 2764/4885 |
| US-20230331639-A1 | METHOD FOR PREPARING DEUTERATED COMPOUND | CYP2F1, CYP21A2, HSD11B2 | MAOA 1073/4885ALDH1A1 2576/4885KDM4E 2336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.